MiR-506 Suppresses Colorectal Cancer Development by Inhibiting Orphan Nuclear Receptor NR4A1 Expression

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Nuclear receptor subfamily 4 group A member 1 (NR4A1) is an oncogene implicated in colorectal cancer (CRC) progression.
• The regulatory mechanisms of NR4A1 expression in CRC remain largely uncharacterized.
• MicroRNAs (miRNAs) are key regulators of gene expression involved in tumor development.

Purpose of the Study:

• To investigate the role of miRNA in regulating NR4A1 expression in colorectal cancer.
• To determine the functional significance of the miR-506/NR4A1 axis in CRC pathogenesis.

Main Methods:

• Bioinformatic analysis (TargetScan) to predict miRNA targets of NR4A1.
• Quantitative real-time PCR and Western blotting to assess NR4A1 and miR-506 expression in CRC tissues and cells.
• Correlation analysis to evaluate the relationship between NR4A1 and miR-506 levels.
• Luciferase reporter assays to confirm direct targeting of NR4A1 by miR-506.
• Cell proliferation, migration, and invasion assays with NR4A1 rescue experiments.

Main Results:

• A miR-506 binding site was identified in the 3'-untranslated region (3'-UTR) of NR4A1.
• NR4A1 expression was upregulated, while miR-506 was downregulated in CRC tissues and cells.
• NR4A1 mRNA levels were negatively correlated with miR-506 levels in CRC.
• miR-506 directly targeted NR4A1 mRNA, leading to decreased NR4A1 expression.
• Overexpression of NR4A1 reversed the inhibitory effects of miR-506 on CRC cell proliferation, migration, and invasion.

Conclusions:

• miR-506 functions as a tumor suppressor in colorectal cancer.
• miR-506 inhibits CRC cell proliferation, migration, and invasion by downregulating NR4A1.
• The miR-506/NR4A1 pathway represents a potential therapeutic target for colorectal cancer.